Möchten Sie immer auf dem neuesten Stand bleiben?

Totaligent (OTCID:TGNT) successfully closed the strategic acqui-hire of the Aetherium Medical platform and team.

The biologics sector is rapidly emerging as one of the most closely watched growth stories in healthcare $HCWB, $TGNT, $MRNA, $REGN

Totaligent (OTCID: TGNT) Targets $273B Medical Tourism Market Via Aetherium Acquisition

The FDA is making AI part of the R&D core infrastructure and companies like Totaligent (OTCID: TGNT) are building the “picks-and-shovels” layer of biotech

Totaligent (OTCID:TGNT) executed a Definitive Agreement with for the strategic acqui-hire of the Aetherium Medical platform and team.

Biotech and healthcare innovators are advancing novel therapies and strategic platforms amid rising demand for targeted treatments and efficient global ac

Recursion OS clinical trial Jensen Huang, NVIDIA’s (NASDAQ:NVDA) CEO, is now pointing to digital biology to be the next technological wave

AI, healthcare technology, and digital infrastructure is a central theme dominating markets: the rapid convergence of AI with data-heavy industries

The Stock Markets are opening with a strong crosscurrent of AI-powered drug discovery, cross-border biologics distribution, and capital structure resets

Totaligent (OTCID: TGNT) signed a binding LOI with GloMed Solutions, a Japanese medical aesthetics and biologics distribution company